Estrogen promotes Epithelial ovarian cancer cells proliferation via down-regulating expression and activating phosphorylation of PTEN
Archives of Biochemistry and Biophysics · 2023
DOI: 10.1016/j.abb.2023.109662 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2023. Verfasst von Xiuwen Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Weifang Medical University, Weifang, Shandong, 261053, PR China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Ovarian Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Epithelial ovarian cancer (EOC) is the most common of cancer death among malignant tumors in women, its occurrence and development are strongly linked to estrogen. Having identified the phosphatase and tensin homologue (PTEN) is a potent tumor suppressor regulating cell proliferation, migration, and survival. Meanwhile, there is a correlation between PTEN protein expression and estrogen receptor expression in EOC. However, no study has amplified on the molecular regulatory mechanism and function between estrogen and PTEN in the development of EOC. In this research, we found that PTEN shows a low expression level in EOC tissues and estrogen decreased PTEN expression via the estrogen receptor 1 (ESR1) in EOC cells. Knockdown of PTEN enhanced the proliferation and migration level of EOC cells driven by estrogen. Moreover, PTEN was also phosphorylated by G protein-coupled receptor 30 (GPR30)-Protein kinase C (PKC) signaling pathway upon estrogen stimulation. Inhibiting the phosphorylation of PTEN weakened the proliferation and migration of estrogen induced-EOC cells estrogen and decreased the phosphorylation of Protein kinase B (AKT) and Mammalian target of rapamycin (mTOR). These results indicated that estrogen decreased PTEN expression level via the ESR1 genomic pathway and phosphorylated PTEN via the GPR30-PKC non-genomic pathway to activate the PI3K/AKT/mTOR signaling pathway, thereby determining the fate of EOC cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Weifang Medical University, Weifang, Shandong, 261053, PR China.
- Plastic Surgery Institute, Weifang Medical University, Weifang, Shandong, 261053, PR China.
- Department of Gastroenterology, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, 100102, PR China.
- Taoyuan People's Hospital, Changde, Hunan, 425700, PR China.
- School of Basic Medical Sciences, Weifang Medical University, Weifang, Shandong, 261053, PR China; Plastic Surgery Institute, Weifang Medical University, Weifang, Shandong, 261053, PR China. Electronic address: wang234d…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, X., Miao, C., Wang, L., Liu, M., Chang, H., Tian, B., & Wang, D. (2023). Estrogen promotes Epithelial ovarian cancer cells proliferation via down-regulating expression and activating phosphorylation of PTEN. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2023.109662
Vancouver
Li X, Miao C, Wang L, Liu M, Chang H, Tian B, et al. Estrogen promotes Epithelial ovarian cancer cells proliferation via down-regulating expression and activating phosphorylation of PTEN. Archives of Biochemistry and Biophysics. 2023. doi:10.1016/j.abb.2023.109662
BibTeX
@article{Li2023,
author = {Li, Xiuwen and Miao, Chunlei and Wang, Lin and Liu, Mengyan and Chang, Huanchao and Tian, Bo and Wang, Di},
title = {Estrogen promotes Epithelial ovarian cancer cells proliferation via down-regulating expression and activating phosphorylation of PTEN},
journal = {Archives of Biochemistry and Biophysics},
year = {2023},
doi = {10.1016/j.abb.2023.109662}
}
EUVIMED